Illustration: Sarah Grillo/Axios. Stock: Getty Images
Biolevate, a French pharma-focused SaaS startup, raised €30 million in Series A funding, CEO Joël Belafa tells Axios Pro exclusively.
Why it matters: Investors continue to back AI-assisted drug discovery and pharma plays.
